Target intelligence / Profile preview

Angiogenic factor with G-patch and FHA domains 1 pseudogene 5 (AGGF1P5)

Target
AGGF1P5
Molecular classification
Other (Processed pseudogene)
01

Overview

AGGF1P5 (angiogenic factor with G-patch and FHA domains 1 pseudogene 5) is a noncoding processed pseudogene; it does not encode a functional protein. In general, pseudogenes are genomic loci that resemble known genes but are rendered nonfunctional by mutations that prevent protein translation. While some pseudogenes have been implicated in RNA-level regulatory roles either as microRNA decoys or modulators of gene expression, there is no evidence that AGGF1P5 itself is biologically active or associated with disease. Accordingly, it is not classified as a receptor, enzyme, or other canonical therapeutic target, and there are no drugs or mechanisms of action associated with it. If you are seeking structured data for computational purposes or database population, please note that the entry for AGGF1P5 should be handled as a non-targetable processed pseudogene, and not as an actionable therapeutic target. If a functional protein or receptor related to angiogenic factor with G-patch and FHA domains 1 (AGGF1) is meant instead, that should be specified and mapped to the canonical, protein-coding AGGF1 entry, not AGGF1P5.

02

Mechanism of action

None (unless acting indirectly in regulatory RNA networks, but no direct evidence for AGGF1P5)

03

Biological functions

Possible regulatory RNA functions (general pseudogene functions such as acting as microRNA decoys or RNA regulators, but no evidence specific to AGGF1P5)
04

Disease associations

Other (Pseudogenes can be involved in cancer or other diseases via RNA-level regulation, but there is no specific evidence for AGGF1P5 itself in the current literature)

Beyond the preview

Go deeper on Angiogenic factor with G-patch and FHA domains 1 pseudogene 5 (AGGF1P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiogenic factor with G-patch and FHA domains 1 pseudogene 5 (AGGF1P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call